Abstract
The role drug resistance plays in the occurrence of chronic and recurrent giardiasis has not been established. Extensive data on the susceptibility to antimicrobial agents of living Giardia spp. trophozoites from human origin are lacking. We have determined with a macrodilution method in semisolid medium the in vitro susceptibility of 25 Giardia lamblia isolates, all obtained by routine cultivation of the duodenal fluid of children to six commonly used antiprotozoal drugs. The results showed tinidazole to be the most active drug (all isolates have MICs of less than or equal to 0.5 micrograms/ml). Metronidazole was equally active on all but one isolate, for which an MIC between 0.5 and 1 micrograms/ml was found. Furazolidone was the most active nonimidazole compound tested. More than 50% of the isolates were very susceptible to paromomycin, pyrimethamine, and chloroquine. Two of the strains presented an MIC for paromomycin higher than 10 micrograms/ml, and six strains needed more than 50 micrograms of pyrimethamine per ml to be inhibited. Decreased susceptibility of several of the isolates to different agents appears to be linked.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bassily S., Farid Z., Mikhail J. W., Kent D. C., Lehman J. S., Jr The treatment of Giardia lamblia infection with mepacrine, metronidazole and furazolidone. J Trop Med Hyg. 1970 Jan;73(1):15–18. [PubMed] [Google Scholar]
- Boreham P. F., Phillips R. E., Shepherd R. W. The sensitivity of Giardia intestinalis to drugs in vitro. J Antimicrob Chemother. 1984 Nov;14(5):449–461. doi: 10.1093/jac/14.5.449. [DOI] [PubMed] [Google Scholar]
- Diamond L. S. Techniques of axenic cultivation of Entamoeba histolytica Schaudinn, 1903 and E. histolytica-like amebae. J Parasitol. 1968 Oct;54(5):1047–1056. [PubMed] [Google Scholar]
- Gillin F. D., Diamond L. S. Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents. J Antimicrob Chemother. 1981 Oct;8(4):305–316. doi: 10.1093/jac/8.4.305. [DOI] [PubMed] [Google Scholar]
- Gordts B., Hemelhof W., Retoré P., Rahman M., Cadranel S., Butzler J. P. Routine culture of Giardia lamblia trophozoites from human duodenal aspirates. Lancet. 1984 Jul 21;2(8395):137–138. doi: 10.1016/s0140-6736(84)91050-x. [DOI] [PubMed] [Google Scholar]
- Jokipii L., Jokipii A. M. In vitro susceptibility of Giardia lamblia trophozoites to metronidazole and tinidazole. J Infect Dis. 1980 Mar;141(3):317–325. doi: 10.1093/infdis/141.3.317. [DOI] [PubMed] [Google Scholar]
- Lerman S. J., Walker R. A. Treatment of giardiasis: literature review and recommendations. Clin Pediatr (Phila) 1982 Jul;21(7):409–414. doi: 10.1177/000992288202100704. [DOI] [PubMed] [Google Scholar]
- Levi G. C., de Avila C. A., Amato Neto V. Efficacy of various drugs for treatment of giardiasis. A comparative study. Am J Trop Med Hyg. 1977 May;26(3):564–565. doi: 10.4269/ajtmh.1977.26.564. [DOI] [PubMed] [Google Scholar]
- Palomino H., Pérez C., Donckaster R., Sapunar J., Gabor M., Atías A., Parodi V., Narbona L. Ensayo terapéutico con cinco medicamentos en lambliasis. Bol Chil Parasitol. 1970 Jan-Jun;25(1):52–56. [PubMed] [Google Scholar]
- Smith P. D., Gillin F. D., Spira W. M., Nash T. E. Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response. Gastroenterology. 1982 Oct;83(4):797–803. [PubMed] [Google Scholar]
- Takeuchi T., Kobayashi S., Tanabe M., Fujiwara T. In vitro inhibition of Giardia lamblia and Trichomonas vaginalis growth by bithionol, dichlorophene, and hexachlorophene. Antimicrob Agents Chemother. 1985 Jan;27(1):65–70. doi: 10.1128/aac.27.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolfe M. S. Giardiasis. JAMA. 1975 Sep 29;233(13):1362–1365. [PubMed] [Google Scholar]